Cyclosporine ophthalmic
Contents
Description
Cyclosporine ophthalmic emulsion is a topical immunomodulator that increases tear production in patients with chronic dry eye and inflammatory ocular surface diseases. It is used off-label for severe vernal conjunctivitis when conventional therapies fail. The medication works by suppressing T-cell mediated inflammation in the conjunctiva and lacrimal glands.
Indications & Therapeutic Use
keratoconjunctivitis sicca, vernal keratoconjunctivitis, chronic dry eye disease
Linked Diseases:
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Cyclosporine ophthalmic — GNH India
66 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | cyclosporine ophthalmic |
| Brands | 1 brand available |
| Active Ingredient | cyclosporine |
| Drug Class | keratoconjunctivitis sicca |
| Manufacturer | Allergan |
| Dosage Forms | ophthalmic emulsion 0.05%, 0.09% |
| Medical Code | S01XA18 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Countries | 7 countries |